Literature DB >> 18084729

Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus.

Simone Appenzeller1, G Bruce Pike, Ann E Clarke.   

Abstract

Central nervous system (CNS) manifestations are often observed in systemic lupus erythematosus (SLE) patients during the course of their disease. The prevalence of CNS manifestations ranges between 17 and 75%, reflecting different methods of patient selection and assessment, varying levels of assessor expertise, and lack of a consensus for diagnosing active and chronic neuropsychiatric (NP) manifestations. Postulated pathogenic mechanisms of peripheral and CNS events include vasculopathy, autoantibody effects, and systemic inflammation. Diagnosis is often difficult because of the lack of standardized diagnostic techniques. Magnetic resonance imaging (MRI) is considered the gold standard for the evaluation of CNS manifestations in SLE patients in clinical practice. MRI findings are diverse, and atrophy and hyperintense white matter lesions often correlate poorly with clinical manifestations, occurring also in patients without marked CNS signs and symptoms. We will describe MRI findings in SLE patients and discuss the usefulness of different MRI techniques in evaluating acute and chronic CNS manifestations.

Entities:  

Mesh:

Year:  2008        PMID: 18084729     DOI: 10.1007/s12016-007-8060-z

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  40 in total

1.  Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images.

Authors:  G B Pike; N De Stefano; S Narayanan; K J Worsley; D Pelletier; G S Francis; J P Antel; D L Arnold
Journal:  Radiology       Date:  2000-06       Impact factor: 11.105

2.  Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus.

Authors:  Simone Appenzeller; Leonardo Bonilha; Pablo A Rio; Li Min Li; Lilan Tereza Lavras Costallat; Fernando Cendes
Journal:  Neuroimage       Date:  2006-11-16       Impact factor: 6.556

Review 3.  To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system.

Authors:  Yehuda Shoenfeld
Journal:  J Autoimmun       Date:  2007-03-26       Impact factor: 7.094

4.  Silent brain infarcts and the risk of dementia and cognitive decline.

Authors:  Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

5.  Voxel-based morphometry of brain SPECT can detect the presence of active central nervous system involvement in systemic lupus erythematosus.

Authors:  S Appenzeller; B J Amorim; C D Ramos; P A Rio; E C S de C Etchebehere; E E Camargo; F Cendes; L T L Costallat
Journal:  Rheumatology (Oxford)       Date:  2006-08-10       Impact factor: 7.580

6.  Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus.

Authors:  R J Chinn; I D Wilkinson; M A Hall-Craggs; M N Paley; E Shortall; S Carter; B E Kendall; D A Isenberg; S P Newman; M J Harrison
Journal:  Arthritis Rheum       Date:  1997-01

7.  Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.

Authors:  H Ainiala; P Dastidar; J Loukkola; T Lehtimäki; M Korpela; J Peltola; A Hietaharju
Journal:  Scand J Rheumatol       Date:  2005 Sep-Oct       Impact factor: 3.641

Review 8.  Imaging modalities in central nervous system systemic lupus erythematosus.

Authors:  T W Huizinga; S C Steens; M A van Buchem
Journal:  Curr Opin Rheumatol       Date:  2001-09       Impact factor: 5.006

Review 9.  MRI and the brain in systemic lupus erythematosus.

Authors:  J W Graham; W Jan
Journal:  Lupus       Date:  2003       Impact factor: 2.911

Review 10.  Psychiatric manifestations in systemic lupus erythematosus.

Authors:  Ljudmila Stojanovich; Gisele Zandman-Goddard; Sanja Pavlovich; Natasa Sikanich
Journal:  Autoimmun Rev       Date:  2007-03-12       Impact factor: 9.754

View more
  25 in total

1.  Reduced Insular Glutamine and N-acetylaspartate in systemic lupus erythematosus: a single-voxel (1)H-MR spectroscopy study.

Authors:  Patricia Cagnoli; Richard E Harris; Dan Frechtling; George Berkis; Richard H Gracley; Courtney C Graft; Suzan E Lowe; Thomas L Chenevert; William J McCune; Stephen Gebarski; Pia C Sundgren
Journal:  Acad Radiol       Date:  2013-10       Impact factor: 3.173

2.  Vasculitis: current status and future directions.

Authors:  Pierre Youinou
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

3.  Cutting edge issues in autoimmunity.

Authors:  Yaniv Sherer; Torsten Matthias; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

4.  Brain MRI in neuropsychiatric lupus: associations with the 1999 ACR case definitions.

Authors:  Hae Woong Jeong; Minyoung Her; Jong Seok Bae; Seong-Kyu Kim; Sung Won Lee; Ho Kyun Kim; Dongyook Kim; Nayoung Park; Won Tae Chung; Sang Yeob Lee; Jung-Yoon Choe; In Joo Kim
Journal:  Rheumatol Int       Date:  2014-10-15       Impact factor: 2.631

5.  Blood pressure and vascular dysfunction underlie elevated cerebral blood flow in systemic lupus erythematosus.

Authors:  Charles Gasparovic; Clifford Qualls; Ernest R Greene; Wilmer L Sibbitt; Carlos A Roldan
Journal:  J Rheumatol       Date:  2012-01-15       Impact factor: 4.666

6.  Mycophenolate mofetil and deflazacort combination in neuropsychiatric lupus: a decade of experience from a tertiary care teaching hospital in southern India.

Authors:  Nikhil Gupta; Arvind Ganpati; Santosh Mandal; John Mathew; Ruchika Goel; Ashish Jacob Mathew; Aswin Nair; Prakash Ramasamy; Debashish Danda
Journal:  Clin Rheumatol       Date:  2017-08-07       Impact factor: 2.980

Review 7.  Cognitive dysfunction and antiphospholipid antibodies.

Authors:  Simone Appenzeller; Aline Tamires Lapa; Jozélio Freire de Carvalho; Fernando Augusto Peres; Yehuda Shoenfeld
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

8.  Juvenile systemic lupus erythematosus with primary neuropsychiatric presentation.

Authors:  Nélia Ferraria; Susana Rocha; Vera Silva Fernandes; Teresa Correia; Elisabete Gonçalves
Journal:  BMJ Case Rep       Date:  2013-01-25

Review 9.  Diagnosis and management of neuropsychiatric SLE.

Authors:  John G Hanly
Journal:  Nat Rev Rheumatol       Date:  2014-02-11       Impact factor: 20.543

10.  Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort study.

Authors:  Yasuhiro Katsumata; Masayoshi Harigai; Yasushi Kawaguchi; Chikako Fukasawa; Makoto Soejima; Tokiko Kanno; Katsuji Nishimura; Takayuki Yamada; Hisashi Yamanaka; Masako Hara
Journal:  BMC Musculoskelet Disord       Date:  2010-01-23       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.